We are live on ! Find out more
KURA icon

Kura Oncology
KURA

99 hedge funds and large institutions have $455M invested in Kura Oncology in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 35 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.61% more ownership

Funds ownership: 79.61% → 85.21% (+5.6%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

0% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 35

14% less capital invested

Capital invested by funds: $529M → $455M (-$74.4M)

15% less funds holding

Funds holding: 116 → 99 (-17)

70% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 23

88% less call options, than puts

Call options by funds: $19K | Put options by funds: $154K

Holders
99
Holders Change
-17
Holders Change %
-14.66%
% of All Funds
2.21%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
7
Increased
35
Reduced
35
Closed
23
Calls
$19K
Puts
$154K
Net Calls
-$135K
Net Calls Change
-$23K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$18.2M
2
BI
BVF Inc
California
+$10.1M
3
GPP
Great Point Partners
Connecticut
+$8.62M
4
CAM
Cormorant Asset Management
Massachusetts
+$7.29M
5
FI
Fosun International
China
+$2.71M

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$7.72M
2
RSCM
Rock Springs Capital Management
Maryland
-$7.09M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.61M
4
Millennium Management
Millennium Management
New York
-$5.53M
5
NC
Nexthera Capital
New York
-$5.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Sio Capital Management
New York
$2.03M -$7.72M -582,847 -80%
CIA
27
Capital Impact Advisors
Massachusetts
$1.84M +$535K +40,415 +42%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.71M +$122K +9,218 +8%
Citigroup
29
Citigroup
New York
$1.57M +$838K +63,241 +130%
AGA
30
Altrinsic Global Advisors
Connecticut
$1.47M +$331K +25,000 +31%
Allianz Asset Management
31
Allianz Asset Management
Germany
$1.29M -$44.2K -3,336 -4%
MA
32
Minerva Advisors
Pennsylvania
$1.24M – – –
AA
33
ALPS Advisors
Colorado
$1.23M +$274K +20,698 +31%
Bank of America
34
Bank of America
North Carolina
$1.13M -$173K -13,090 -14%
CCP
35
Clough Capital Partners
Massachusetts
$1.13M – – –
Morgan Stanley
36
Morgan Stanley
New York
$846K +$70.4K +5,314 +10%
Squarepoint
37
Squarepoint
New York
$769K -$121K -9,124 -14%
SCA
38
Secor Capital Advisors
New York
$744K +$447K +33,722 +175%
TA
39
Teachers Advisors
New York
$716K – – –
UBS Group
40
UBS Group
Switzerland
$705K +$573K +43,281 +619%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$662K +$54.5K +4,115 +10%
TCIM
42
TIAA CREF Investment Management
New York
$657K +$67.9K +5,127 +12%
Swiss National Bank
43
Swiss National Bank
Switzerland
$592K – – –
Citadel Advisors
44
Citadel Advisors
Florida
$544K +$145K +10,961 +39%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$521K +$183K +13,781 +59%
Wells Fargo
46
Wells Fargo
California
$485K -$102K -7,701 -18%
CC
47
Caxton Corporation
New Jersey
$461K -$24.9K -1,880 -5%
B
48
Bailard
California
$421K – – –
PPCM
49
Pillar Pacific Capital Management
California
$409K – – –
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$407K +$41.1K +3,100 +12%
1
2
3 4 5

KURA Hedge Fund Activity: Q4 2018 in Review

99 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2018, worth a combined $455M — down 14% from $529M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of KURA and 7 opened new positions — a net loss of 16 holders — while 35 trimmed existing stakes and 35 added.

The largest buyer was EcoR1 Capital, adding an estimated $18.2M. The largest seller was Sio Capital Management, cutting an estimated $7.72M.

  • 99 institutional investors held Kura Oncology (KURA) as of Q4 2018, down from 116 in Q3 2018.
  • Funds reported $455M of Kura Oncology stock for Q4 2018, down 14% quarter-over-quarter.
  • 7 funds opened new Kura Oncology positions in Q4 2018 and 23 closed out, a net change of -16 holders.
  • The largest Kura Oncology buyer in Q4 2018 was EcoR1 Capital, an estimated $18.2M added.
  • The largest Kura Oncology seller in Q4 2018 was Sio Capital Management, an estimated $7.72M sold.

Based on aggregated 13F filings for Q4 2018.